Introduction
Patients with 'essential' or idiopathic diabetes me]litus have increased insulin antagonism associated with their plasma albumin --an exaggeration of that also found in the albumin fraction from healthy people [11] . In the physiological range of concentration (3.5--5.5 g per 100 ml), both diabetic and normal albumin completely inhibit the effect of 1000 microunits per ml of insulin added in vitro to the incubation medium [13] . At 1.25 g per 100 ml however, the albumin from essential diabetics as well as those constituted as diabetics, is still highly antagonistic (synalbumin positive), whereas albumin prepared frora healthy subjects does not exhibit insulin antagonism (synalbumin negative). Recent in vivo studies lend further support to these observations [7, 8] .
Synalbumin insulin antagonism changes during oral and intravenous glucose tolerance tests, the antagonism being inversely proportional to the glucose levels in the blood [6] ; which suggests that the effectiveness of any circulating insulin is modified by alterations in synalbumin antagonism which in turn are mediated through changes in blood sugar. In previous studies the blood glucose rose initially; accordingly we have studied intravenous tolbutamide tolerance tests where the immediate response is a fall in glucose levels. * Present Address: The All India Institute of Medical Sciences, New Delhi, India
Volunteers and Methods
Eighteen healthy doctors and laboratory personnel, aged 20--27, were studied after a twelve hour fast. After withdrawing fasting blood sample in a heparinised syringe, 20 ml of 5% sodium tolbutamide was injected intravenously during a two minute period; the midpoint of injection was considered as zero minute and subsequent blood samples were collected at thirty, sixty and ninety minute intervals. The subjects were rested for the duration of the test. The glucose concentration was estimated in all samples. Albumin was extracted from the plasma by a modification [13] of the Debro method [2] .
In two volunteers, blood samples were collected in nonheparinised dry syringes and after taking adequate aliquots for glucose estimation, blood was allowed to clot. Serum was separated and albumin was prepared by the Fernandez method [4] which does not require the use of trichloracetic acid or dialysis; albumin prepared by this method has previously been found to be equipotent to that prepared by the Debro method, regarding insulin antagonism [18] .
Insulin antagonism was determined by the ratdiaphragm procedure [15, 16] . Albumin extracts were dissolved in buffer solution [5] containing glucose (300 mg per 100 ml) ; insoluble matter was removed by centrifugation. Insulin was added to the buffer alone and to the buffer containing 2.5 g albumin per 100 ml to make a final concentration of 1000 microunits per J.S. Bajaj and J. Vallance-Owen: Variations in Synalbumin Insulin Antagonism Diabetologia ml. This concentration of albumin is the same as that used in the previous study of synalbumin changes during glucose tolerance test [6] . The glucose uptake of the diaphragms was determined in: [1] buffer alone; [2] buffer and insulin; and [3] buffer and 2.5% albumin in the presence of insulin. All the samples from one tolbutamide test were assayed in any one experiment, thereby facilitating the comparison between antagonistic effects of samples taken during the same test. 
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Insulin effect without albumin. Figure 1 shows the mean values for the effect of insulin in the presence of 2.5 g albumin per 100 ml, extracted at various time intervals after tolbutamide administration. In all the volunteers, the insulin effect on the diaphragm showed a significant decrease at 30 min; this coincided with the peak hypoglyeaemic response in the subjects. Clinical symptoms of hypoglycaemia were noticed in five individuals; their blood glucose concentration ranged between 27--40 rag% at this point. The increased antagonism at 30 min returned to the pre-tolbutamide levels at 90 rain. There was no difference in these results when the albumin was extracted by the Fernandez method, therefore all the results have been given together in the figure.
Discussion
In healthy volunteers, the level of synalbumin insulin antagonism varies considerably and consistently after intravenous administration of sodium tolbutamide; it increases significantly thirty minutes after the injection and subsequently tends to fall to the inital fasting levels by 90 rain.
In contrast to these findings, Devrim et al. [3] in six normal subjects found that the increased antagonism at 30 rain after tolbutamide continued to rise up to 120 min and suggested that this was due to the rise in plasma insulin following intravenous tolbutamide. However, glucose also causes a rise in plasma insulin but with a fall in antagonism [6] . Thus from this observation and the studies reported here the changes in synalbumin are related inversely to the blood sugar.
There is considerable evidence that the synalbumin antagonist is identical with the B Chain of insulin [12] and liver contains a high concentration of glutathione insulin transhydrogenase which breaks the insulin molecules into its component A and B Chains [9, 10] . Moreover, hypophysectomy [14] and adrenalectemy [17] are known to reduce the level of synMbumin antagonism and growth hormone stimulates glutathione insulin transhydrogenase [1] . Thus the short term variations in the level of synalbumin antagonism after tolbutamide as well as those previously reported after glucose administration could well be due to changes in pituitary-adrenal activity which in turn is governed by acute fluctuations in blood sugar.
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